Global Prostate Cancer Diagnostics Market Data Survey Report 2025
- HEY2147670
- 90 Pages
- October 2017
- Healthcare
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Abbott
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Major applications as follows:
< 55
55-75
> 75
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Abbott
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Genomic Health
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 OPKO
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Siemens Healthcare
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 DiaSorin
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 bioMeriux
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Roche
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 MDx Health
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Beckman Coulter
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Myriad Genetics
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Ambry Genetics
4 Major Application
4.1 < 55
4.1.1 Overview
4.1.2 < 55 Market Size and Forecast
4.2 55-75
4.2.1 Overview
4.2.2 55-75 Market Size and Forecast
4.3 > 75
4.3.1 Overview
4.3.2 > 75 Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Abbott
Tab Sales Revenue, Volume, Price, Cost and Margin of Genomic Health
Tab Sales Revenue, Volume, Price, Cost and Margin of OPKO
Tab Sales Revenue, Volume, Price, Cost and Margin of Siemens Healthcare
Tab Sales Revenue, Volume, Price, Cost and Margin of DiaSorin
Tab Sales Revenue, Volume, Price, Cost and Margin of bioMeriux
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche
Tab Sales Revenue, Volume, Price, Cost and Margin of MDx Health
Tab Sales Revenue, Volume, Price, Cost and Margin of Beckman Coulter
Tab Sales Revenue, Volume, Price, Cost and Margin of Myriad Genetics
Tab Sales Revenue, Volume, Price, Cost and Margin of Ambry Genetics
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Prostate Cancer Diagnostics Market Size and CAGR 2011-2017 (Value)
Fig Global Prostate Cancer Diagnostics Market Size and CAGR 2011-2017 (Volume)
Fig Global Prostate Cancer Diagnostics Market Forecast and CAGR 2018-2025 (Value)
Fig Global Prostate Cancer Diagnostics Market Forecast and CAGR 2018-2025 (Volume)
Fig < 55 Market Size and CAGR 2011-2017 (Value)
Fig < 55 Market Size and CAGR 2011-2017 (Volume)
Fig < 55 Market Forecast and CAGR 2018-2025 (Value)
Fig < 55 Market Forecast and CAGR 2018-2025 (Volume)
Fig 55-75 Market Size and CAGR 2011-2017 (Value)
Fig 55-75 Market Size and CAGR 2011-2017 (Volume)
Fig 55-75 Market Forecast and CAGR 2018-2025 (Value)
Fig 55-75 Market Forecast and CAGR 2018-2025 (Volume)
Fig > 75 Market Size and CAGR 2011-2017 (Value)
Fig > 75 Market Size and CAGR 2011-2017 (Volume)
Fig > 75 Market Forecast and CAGR 2018-2025 (Value)
Fig > 75 Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
